col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


56 Results       Page 1

 [1] 
Elsevier: Contemporary Clinical Trials
  original article Date Title Authors   All Authors
1 [GO] 2023―Jan―16 A rank-based approach to design and analysis of pretest-posttest randomized trials, with application to COVID-19 ordinal scale data Guangyong Zou, Emma J. Smith, Lily Zou, Shi-Fang Qiu, Di Shu
2 [GO] 2023―Jan―09 Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation Samira Reyes Dassum, Ryan Ferguson, Patricia Woods, Maura Flynn, Karen Visnaw, Erika Holmberg, et al. (+6)
3 [GO] 2022―Dec―17 Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trial Julie H. Levison, David Krane, Karen Donelan, Kelly Aschbrenner, Hao D. Trieu, Cindy Chau, et al. (+17)
4 [GO] 2022―Dec―05 How much did it cost to develop and implement an eHealth intervention for a minority children population that overlapped with the COVID-19 pandemic Alexandra Monashefsky, Dar Alon, Tom Baranowski, Tiago V. Barreira, Kelly A. Chiu, Amy Fleischman, et al. (+6)
5 [GO] 2022―Nov―25 Designing a virtual mental health consultation program to support and strengthen childcare centers impacted by COVID-19: A randomized controlled trial protocol Ruby Natale, Yaray Agosto, Rebecca J. Bulotsky-Shearer, Sara M. St. George, Jason Jent
6 [GO] 2022―Nov―08 Distribution of age, sex, race, and ethnicity in COVID-19 clinical drug trials in the United States: A review Daniel B. Chastain, Vishwa S. Patel, Alexandria M. Jefferson, Sharmon P. Osae, Joeanna S. Chastain, Andrés F. Henao-Martínez, et al. (+2)
7 [GO] 2022―Nov―05 Reaching high-risk Black adults for diabetes prevention programming during a pandemic: The design of Fit & Faithful a randomized controlled community trial Lovoria B. Williams, Debra K. Moser, Alison Gustafson, Teresa M. Waters, Mary Kay Rayens, Erika R. Karle, Andrea M. Kriska
8 [GO] 2022―Sep―22 The association between non-English primary language and COVID-19 clinical trial eligibility and enrollment: A retrospective cohort study Sarah D. Tait, Chana A. Sacks, Michael Dougan, Keri Sullivan, Alexander C. Tsai, Thomas H. McCoy, Crystal M. North
9 [GO] 2022―Aug―21 Successful recruitment of monolingual Spanish speaking Latinos to university phase II and III outpatient COVID-19 clinical treatment trials in Northern California Vivian Levy, Ruth Yanes Bengoa, Priscilla Padilla Romero, Jenna Bollyky, Upinder Singh
10 [GO] 2022―Jun―11 The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial Erin K. McCreary, J. Ryan Bariola, Tami E. Minnier, Richard J. Wadas, Judith A. Shovel, Debbie Albin, et al. (+35)
11 [GO] 2022―Jun―09 A pragmatic randomized trial of home-based testing for COVID-19 in rural Native American and Latino communities: Protocol for the “Protecting our Communities” study Matthew J. Thompson, Paul K. Drain, Charlie E. Gregor, Laurie A. Hassell, Linda K. Ko, Victoria Lyon, et al. (+10)
12 [GO] 2022―May―26 Clinic navigation and home visits to improve asthma care in low income adults with poorly controlled asthma: Before and during the pandemic Andrea J. Apter, Tyra Bryant-Stephens, Xiaoyan Han, Hami Park, Anna Morgan, Heather Klusaritz, et al. (+4)
13 [GO] 2022―May―07 Implementing expanded COVID-19 testing in Massachusetts community health centers through community partnerships: Protocol for an interrupted time series and stepped wedge study design Gina Kruse, Leslie Pelton-Cairns, Elsie Taveras, Susan Dargon-Hart, Daniel A. Gundersen, Rebekka M. Lee, et al. (+6)
14 [GO] 2022―Apr―22 Protecting the mental and physical well-being of frontline health care workers during COVID-19: Study protocol of a cluster randomized controlled trial Lu Dong, Lisa S. Meredith, Carrie Farmer, Sangeeta Ahluwalia, Peggy Chen, Kathryn Bouskill, et al. (+9)
15 [GO] 2022―Apr―20 One committee to review them all: A single, multi-disciplinary COVID-19 research committee Jocelyn Migliacci, Ann Rodavitch, Gregory Riely, Paul Sabbatini, Collette Houston, Sara Hanley
16 [GO] 2022―Apr―06 Handling death as an Intercurrent event in time to recovery analysis in COVID-19 treatment clinical trials Hong Li, Kevin J. Gleason, Yiran Hu, Sandra S. Lovell, Saurabh Mukhopadhyay, Li Wang, Bidan Huang
17 [GO] 2022―Apr―04 The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design Konrad Rejdak, Piotr Fiedor, Robert Bonek, Aleksander Goch, Agnieszka Gala-Błądzińska, Waldemar Chełstowski, et al. (+9)
18 [GO] 2022―Mar―21 Impact of COVID-19 pandemic on oncology clinical trial design, data collection and analysis Rui (Sammi) Tang, Jian Zhu, Tai-Tsang Chen, Fang Liu, Xun Jiang, Bo Huang, et al. (+2)
19 [GO] 2022―Feb―16 COVID-19 interventional trials: Analysis of data sharing intentions during a time of pandemic Kristina Larson, Ida Sim, Megan von Isenburg, Marcia Levenstein, Frank Rockhold, Stan Neumann, et al. (+4)
20 [GO] 2022―Feb―08 COVID-19 vaccines: Considering sex differences in efficacy and safety Adelaide Jensen, Masha Stromme, Shayda Moyassari, Antonella Santuccione Chadha, Maria Carmela Tartaglia, Cassandra Szoeke, Maria Teresa Ferretti
21 [GO] 2022―Jan―16 The use of telecommunication and virtualization among ongoing and discontinued COVID-19 clinical trials: A cross-sectional analysis Mary C. Greenough, Nicholas B. Sajjadi, Brayden Rucker, Matt Vassar, Micah Hartwell
22 [GO] 2021―Dec―09 Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days Erin K. McCreary, J. Ryan Bariola, Tami Minnier, Richard J. Wadas, Judith A. Shovel, Debbie Albin, et al. (+21)
23 [GO] 2021―Nov―23 Modified Application of Cardiac Rehabilitation in Older Adults (MACRO) Trial: Protocol changes in a pragmatic multi-site randomized controlled trial in response to the COVID-19 pandemic Daniel E. Forman, Susan B. Racette, Pamela E. Toto, Linda R. Peterson, Nancy W. Glynn, Jennifer Pruskowski, et al. (+8)
24 [GO] 2021―Nov―15 Implementation of platform trials in the COVID-19 pandemic: A rapid review Alyssa M. Vanderbeek, Judith M. Bliss, Zhulin Yin, Christina Yap
25 [GO] 2021―Nov―12 Assessing the impact of the COVID-19 pandemic on pragmatic clinical trial participants Brian C. Coleman, Natalie Purcell, Mary Geda, Stephen L. Luther, Peter Peduzzi, Robert D. Kerns, et al. (+8)
26 [GO] 2021―Oct―29 Developing a virtual assessment protocol for the AMPLIFI Randomized Controlled Trial due to COVID-19: From assessing participants' preference to preparing the team Maria Pisu, Iman Omairi, Teri Hoenemeyer, Karina I. Halilova, Yu-Mei M. Schoenberger, Laura Q. Rogers, et al. (+7)
27 [GO] 2021―Oct―14 Japanese project for telepsychiatry evaluation during COVID-19: Treatment comparison trial (J-PROTECT): Rationale, design, and methodology Taishiro Kishimoto, Shotaro Kinoshita, Shogyoku Bun, Yasunori Sato, Momoko Kitazawa, Toshiaki Kikuchi, et al. (+25)
28 [GO] 2021―Oct―02 The COVID-19 Self-Testing through Rapid Network Distribution (C-STRAND) trial: A randomized controlled trial to increase COVID-19 testing in underserved populations Cedric H. Bien-Gund, Jesal Shah, Joshua I. Ho, Alisa Stephens-Shields, Kathleen Shea, Jessica Fishman, et al. (+4)
29 [GO] 2021―Sep―28 Modified Reference Based Imputation and Tipping Point Analysis In the Presence of Missing Data Due to COVID-19 Man Jin, Ran Liu, Weining Robieson
30 [GO] 2021―Aug―28 Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial Tayyab Shah, Marianne McCarthy, Irem Nasir, Herb Archer, Elio Ragheb, Jonathan Kluger, et al. (+16)
31 [GO] 2021―Aug―13 Rationale and design of the prone position and respiratory outcomes in non-intubated COVID-19 patients: The “PRONE” study Eugene Friedman, John Franzone, Emily Ray Ko, Kristin Corey, Jason Mock, Naseem Alavian, et al. (+11)
32 [GO] 2021―Jul―16 The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trial Bryan Bunning, Haley Hedlin, Natasha Purington, Vandana Sundaram, Kristopher Kapphahn, Yingjie Weng, et al. (+11)
33 [GO] 2021―Jul―02 An innovative protocol for the artificial speech-directed, contactless administration of laboratory-based comprehensive cognitive assessments: PAAD-2 trial management during the COVID-19 pandemic K. Shin Park, Jennifer L. Etnier
34 [GO] 2021―May―29 The link between vitamin D and COVID-19 Daniel M.O. Campos, Edilson D. Silva Jr, Umberto L. Fulco, Jonas I.N. Oliveira
35 [GO] 2021―May―29 Response to the letter to the editor: “The link between Vitamin D and COVID-19” Davaasambuu Ganmaa, Rui Wang, Walter C. Willett, JoAnn E. Manson
36 [GO] 2021―Apr―20 Considerations for assessing physical function and physical activity in clinical trials during the COVID-19 pandemic Seol Ju E. Moon, Annette DeVito Dabbs, Andrea L. Hergendroeder, Melissa L. Vendetti, Kristen B. Jones, Bryan M. Willey, et al. (+2)
37 [GO] 2021―Mar―26 Risk-based centralized data monitoring of clinical trials at the time of COVID-19 pandemic Most Alina Afroz, Grant Schwarber, Mohammad Alfrad Nobel Bhuiyan
38 [GO] 2021―Mar―12 A multi-center trial of exercise and testosterone therapy in women after hip fracture: Design, methods and impact of the COVID-19 pandemic Ellen F. Binder, Jesse C. Christensen, Jennifer Stevens-Lapsley, Jenna Bartley, Sarah D. Berry, Adrian S. Dobs, et al. (+12)
39 [GO] 2021―Feb―23 RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19 Veeral Ajmera, Wesley K. Thompson, Davey M. Smith, Atul Malhotra, Ravindra L. Mehta, Vaishal Tolia, et al. (+6)
40 [GO] 2021―Jan―27 Clinical trial preparations for the next pandemic Jay Herson
41 [GO] 2021―Jan―10 Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials Ahmad Al-Abdouh, Anas Bizanti, Mahmoud Barbarawi, Ahmad Jabri, Ashish Kumar, Oluwaseun E. Fashanu, et al. (+4)
42 [GO] 2020―Dec―18 Guest Editors'-in-Chief Note to COVID-19 Special Issue. Zheng Su, Sue-Jane Wang
43 [GO] 2020―Dec―04 Reporting and design of randomized controlled trials for COVID-19: A systematic review Alison Dillman, Jay J.H. Park, Michael J. Zoratti, Noor-E Zannat, Zelyn Lee, Louis Dron, et al. (+6)
44 [GO] 2020―Nov―11 Causal inference methods for small non-randomized studies: Methods and an application in COVID-19 Sarah Friedrich, Tim Friede
45 [GO] 2020―Nov―10 Reacting to crises: The COVID-19 impact on biostatistics/epidemiology Robert T. O'Neill
46 [GO] 2020―Nov―02 Modifications to communities for healthy Living trial design resulting from COVID-19 Kirsten K. Davison, Sebastien Hanuese
47 [GO] 2020―Oct―23 Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country Geert Molenberghs, Marc Buyse, Steven Abrams, Niel Hens, Philippe Beutels, Christel Faes, et al. (+13)
48 [GO] 2020―Oct―10 The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design Rui Wang, Victor DeGruttola, Quanhong Lei, Kenneth H. Mayer, Susan Redline, Aditi Hazra, et al. (+4)
49 [GO] 2020―Oct―06 TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol Maria Carmela Piccirillo, Paolo Ascierto, Luigi Atripaldi, Marco Cascella, Massimo Costantini, Giovanni Dolci, et al. (+15)
50 [GO] 2020―Sep―20 Data monitoring committees for clinical trials evaluating treatments of COVID-19 Tobias Mütze, Tim Friede
51 [GO] 2020―Sep―20 COVID-19 hits a trial: Arguments against hastily deviating from the plan Anika Großhennig, Armin Koch
52 [GO] 2020―Sep―15 Semiparametric Bayesian inference for the transmission dynamics of COVID-19 with a state-space model Tianjian Zhou, Yuan Ji
53 [GO] 2020―Sep―12 Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19 Zachary R. McCaw, Lu Tian, Kevin N. Sheth, Wan-Ting Hsu, W. Taylor Kimberly, Lee-Jen Wei
54 [GO] 2020―Aug―08 Covid-19 pandemic research opportunity: Is the Middle East & North Africa (MENA) missing out? Halah Ibrahim, Ashraf M. Kamour, Thana Harhara, Waqar H. Gaba, Satish C. Nair
55 [GO] 2020―Aug―06 The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan Hsiao-Hui Tsou, Yu-Chieh Cheng, Hsiang-Yu Yuan, Ya-Ting Hsu, Hsiao-Yu Wu, Fang-Jing Lee, et al. (+7)
56 [GO] 2020―Apr―06 Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research? Hala T. Borno, Eric J. Small
 [1] 

56 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec